Repligen | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Agilent USD 1.47B 138M 2025-01
Align Technology USD 1.04B 1.95M 2024-12
Bio Techne USD 177.55M 9.99M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Bruker USD 183.4M 35.3M 2024-12
Charles River Laboratories USD 194.61M 15.56M 2024-12
Danaher USD 2.08B 549M 2024-12
Dentsply International USD 272M 24M 2024-12
Exact Sciences USD 5.34M 748K 2024-12
General Electric USD 13.62B 295M 2024-12
Henry Schein USD 122M 4M 2024-12
Illumina USD 1.13B 258M 2024-12
IQVIA Holdings USD 1.7B 130M 2024-12
Mettler Toledo International USD 59.36M 12.21M 2024-12
Myriad Genetics USD 102.4M 2.5M 2024-12
Patterson Companies USD 135M 22.94M 2025-01
Pfizer USD 1.04B 49M 2024-12
Repligen USD 783.96M 25.19M 2024-09
Revvity USD 1.16B 66.38M 2024-12
Standard Biotools USD 166.73M 43.92M 2024-12
Thermo Fisher Scientific USD 4.01B 636M 2024-12
Waters USD 324.42M 6.09M 2024-12
West Pharmaceutical Services USD 484.6M 6.3M 2024-12



Repligen Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.